According to the Enterprise Check App, recently, Hubei Minghuikang Biomedical Technology Co., Ltd. was established, with Wang Rui as the legal representative and a registered capital of 3 million yuan. Its business scope includes: research and development of fermentation process optimization technology; sales of health food (pre-packaged); integration services of AI industry applications; health consulting services; remote health management services, etc. Equity penetration information from Enterprise Check App shows that this company is indirectly wholly owned by Wuhan Easy Diagnosis Biomedicine.
明德生物投资成立科技新公司 含AI相关业务
Wuhan Easy Diagnosis Biomedicine investment established a new technology company including AI-related business.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated